It is a pharma private limited company based in Chandigarh, Chandigarh, India, established in 2020.
2020 | Chandigarh, Chandigarh, India | ActiveStyla Pharmaceutical Private Limited, a active private limited company, was established on 24 November 2020 in Chandigarh, Chandigarh, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24230CH2020PTC043353. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.20 M.
Its leadership includes Paraspreet Singh (Director), Gaurav Sardana (Director), Sukhwinder Kaur (Director). Past directors included Smriti Biswas. It holds ₹5.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Shop No. 460,Ground Floor,Dera Sahib Mohalla, Samadhi Gate,Manimajra, Chandigarh, Chandigarh, 160101.
U24230CH2020PTC043353
043353
24 November 2020
₹1.00 M
₹0.20 M
Roc Chandigarh
Unlisted
Active
Explore comprehensive insights into Styla Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Paraspreet Singh | Director | 18 May 2023 | Current |
| Gaurav Sardana | Director | 11 Nov 2024 | Current |
| Sukhwinder Kaur | Director | 24 Nov 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 17 May 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Styla Pharmaceutical Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 47047.83% increase. The company also saw a substantial fall in profitability, with a 527.85% decrease in profit. The company's net worth observed a substantial decline by a decrease of 49.33%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Styla Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹5,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Feb 2025 | Canara Bank | ₹5.00 M | Open |
Explore comprehensive loan charge details -
Styla Pharmaceutical has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Styla Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Styla Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Canara Bank amounted to Rs. 5.00 M with Charge ID 101049404 was registered on 04 Feb 2025. was documented.
The activity Gaurav Sardana was appointed as a Director was appointed as a Director on 11 Nov 2024 & has been associated with this company since 1 year 20 days . was completed.
The activity Styla Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Styla Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh. was recorded as a recent event.
The activity Paraspreet Singh was appointed as a Director was appointed as a Director on 18 May 2023 & has been associated with this company since 2 years 6 months . was completed.
Progress on Sukhwinder Kaur was appointed as a Director was appointed as a Director on 24 Nov 2020 & has been associated with this company since 5 years 7 days . was documented.
The CIN of Styla Pharmaceutical Private Limited is U24230CH2020PTC043353.
Styla Pharmaceutical Private Limited is headquartered at Shop No. 460,Ground Floor,Dera Sahib Mohalla, Samadhi Gate,Manimajra, Chandigarh, Chandigarh, 160101.
Styla Pharmaceutical Private Limited was incorporated on 24 November 2020.
The current directors of Styla Pharmaceutical Private Limited are
The primary industry of Styla Pharmaceutical Private Limited is Pharma.
Styla Pharmaceutical Private Limited is unlisted.
The authorized capital of Styla Pharmaceutical Private Limited is ₹1.00 M, and the paid-up capital is ₹0.20 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX